The effect of short course high dose methylprednisolon therapy on fibrinogen level in children with acute lymphoblastic leukemia: A preliminary study

Leukemia Research

Volumn 28, Issue 5, 2004, Pages 533-535

  Toksöz, Hayri ^a   Ünal, Selma ^a   Kirazli, Şerafettin ^a   Gürgey, Aytemiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; D dimer; Fibrinogen; Methylprednisolon; PAI I; Plasminogen

Indexed keywords

ASPARAGINASE; D DIMER; DAUNORUBICIN; METHYLPREDNISOLONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFANT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; METHYLPREDNISOLONE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 1842611798     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.09.012     Document Type: Article

References (12)

1. Guarini A., Mussoni L., Gugliotta L. Depressed fibrinolysis in patients with acute leukaemia. Br. J. Haemotol. 66:1987;327-330.
2. Sutor A.H., Niemeyer C., Sauter S., Witt I., Kaufmehl K., Rombach A.et al. Alteration of hemostasis with the treatment protocols ALL-BFM 90 and NHL-BFM 90. Klin. Pediatr. 204:1992;264-273.
3. Totan M., Daǧdemir A., Ak A.L., Albayrak D., Küçü ködük Ş. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 36:2001;429-433.
4. Semeraro N., Montemurro P., Giordano P., Schettin F., Santaro N. Unbalanced coagulation-fibrinolysis potential during L-Asparaginase theraphy in children with acute lymphoblastic leukemia. Thromb. Haemost. 64:1990;38-40.
5. Mitchell L.G., Halton J.M., Vegh P.A., Barr R.D., Venneri T., Pai K.M. Effect of disease and chemotheraphy on hemostasis in children with acute lymphoid leukemia. Am. J. Pediatr. Hematol. Oncol. 16:1994;120-126.
6. Goldschmidt B., Koos R. Metabolism of fibrinogen in children with acute lymphoblastic leukemia. Eur. J. Pediatr. 143:1984;140-144.
7. William R.B. The fibrinolytic system in neoplasia. Semin. Thromb. Hemost. 22:1996;459-478.
8. Isacson S. Effect of prednisolone on the coagulation and fibrinolytic systems. Scand. J. Heamat. 7:1970;212-216.
9. Öner A.F., Gürgey A., Kirazli Ş., Okur H., Tunç B. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotheraphy including high dose methylprednisolone and L-Asparaginase. Leukemia Lymphoma. 33:1999;361-364.
10. Al-Mondhiry H., Lawlor D., Sadula D. Fibrinogen survival and fibrinolysis in acute leukemia. Cancer. 35:1975;432-435.
11. Gralnick H.R., Henderson E. Hypofibrinogenemia and coagulation factor deficiences with L-asparaginase treatment. Cancer. 18:1970;1313-1319.
12. Veronica A., Carroll P.H., Bernard R.B. The role of the plazminogen activation system in cancer. Semin. Thromb. Hemost. 25:1999;183-197.